These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions. Nauck MA; Meier JJ Lancet Diabetes Endocrinol; 2016 Jun; 4(6):525-36. PubMed ID: 26876794 [TBL] [Abstract][Full Text] [Related]
12. Incretin hormone mimetics and analogues in diabetes therapeutics. Green BD; Flatt PR Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):497-516. PubMed ID: 18054732 [TBL] [Abstract][Full Text] [Related]
13. [Incretin and bone]. Yamada Y Clin Calcium; 2009 Sep; 19(9):1312-7. PubMed ID: 19721203 [TBL] [Abstract][Full Text] [Related]
14. Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via Interleukin 6, Produced by α Cells. Timper K; Dalmas E; Dror E; Rütti S; Thienel C; Sauter NS; Bouzakri K; Bédat B; Pattou F; Kerr-Conte J; Böni-Schnetzler M; Donath MY Gastroenterology; 2016 Jul; 151(1):165-79. PubMed ID: 26971825 [TBL] [Abstract][Full Text] [Related]
15. The Role of Incretins on Insulin Function and Glucose Homeostasis. Holst JJ; Gasbjerg LS; Rosenkilde MM Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33782700 [TBL] [Abstract][Full Text] [Related]
16. The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update. Nauck MA; Quast DR; Wefers J; Pfeiffer AFH Diabetes Obes Metab; 2021 Sep; 23 Suppl 3():5-29. PubMed ID: 34310013 [TBL] [Abstract][Full Text] [Related]
17. Update on incretin hormones. Phillips LK; Prins JB Ann N Y Acad Sci; 2011 Dec; 1243():E55-74. PubMed ID: 22545749 [TBL] [Abstract][Full Text] [Related]
18. The entero-insular axis: implications for human metabolism. Ranganath LR Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966 [TBL] [Abstract][Full Text] [Related]
19. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants. Holst JJ; McGill MA Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 27933595 [TBL] [Abstract][Full Text] [Related]
20. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'. Skow MA; Bergmann NC; Knop FK Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]